glp-1 market forecast Agonists Weight Loss Drugs Report, 2025-2030 GLP-1 Receptor Agonist Market Size
Description
No referrals to strangers
Will weight loss slow down after 6 months
The drug was approved based on research showing that 63 percent of people who took semaglutide cleared their MASH within 72 weeks compared to 34 percent of people taking a placebo
In an April 2024 letter to Novo Nordisk, the senator notes that while Novo Nordisk charges $1,349 a month for Wegovy in the US, the drug costs just $187 a month in Denmark, $137 a month in Germany and $92 a month in the UK
